Aflac Incorporated (NYSE:AFL) Holdings Decreased by Weaver C. Barksdale & Associates Inc.

Weaver C. Barksdale & Associates Inc. reduced its position in Aflac Incorporated (NYSE:AFL) by 1.6% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 26,901 shares of the financial services provider’s stock after selling 430 shares during the period. Aflac comprises about 2.3% of Weaver C. Barksdale & Associates Inc.’s holdings, making the stock its 4th largest position. Weaver C. Barksdale & Associates Inc.’s holdings in Aflac were worth $2,403,000 at the end of the most recent reporting period.

Several other institutional investors also recently bought and sold shares of AFL. Crossmark Global Holdings Inc. boosted its position in Aflac by 22.6% in the 4th quarter. Crossmark Global Holdings Inc. now owns 86,010 shares of the financial services provider’s stock valued at $7,096,000 after buying an additional 15,855 shares during the last quarter. Southeast Asset Advisors Inc. raised its stake in Aflac by 0.4% in the 4th quarter. Southeast Asset Advisors Inc. now owns 139,164 shares of the financial services provider’s stock worth $11,481,000 after purchasing an additional 589 shares in the last quarter. Nordea Investment Management AB increased its position in shares of Aflac by 6.7% in the first quarter. Nordea Investment Management AB now owns 1,806,475 shares of the financial services provider’s stock worth $155,140,000 after purchasing an additional 113,226 shares during the period. Richard C. Young & CO. LTD. acquired a new position in Aflac during the fourth quarter valued at approximately $12,546,000. Finally, Stifel Financial Corp lifted its stake in Aflac by 7.6% in the 4th quarter. Stifel Financial Corp now owns 633,472 shares of the financial services provider’s stock valued at $52,262,000 after purchasing an additional 44,875 shares during the last quarter. 67.44% of the stock is currently owned by institutional investors.

Insider Transactions at Aflac

In other news, Director Thomas J. Kenny sold 2,000 shares of the stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $98.94, for a total transaction of $197,880.00. Following the transaction, the director now owns 18,158 shares of the company’s stock, valued at approximately $1,796,552.52. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 0.90% of the stock is currently owned by insiders.

Aflac Stock Performance

NYSE:AFL opened at $107.87 on Friday. The company has a current ratio of 0.10, a quick ratio of 0.10 and a debt-to-equity ratio of 0.29. Aflac Incorporated has a twelve month low of $74.89 and a twelve month high of $111.14. The firm has a 50-day moving average price of $102.57 and a two-hundred day moving average price of $91.68. The company has a market capitalization of $61.29 billion, a P/E ratio of 11.91, a price-to-earnings-growth ratio of 2.53 and a beta of 0.95.

Aflac (NYSE:AFL) last issued its earnings results on Wednesday, July 31st. The financial services provider reported $1.83 EPS for the quarter, topping the consensus estimate of $1.60 by $0.23. The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $4.10 billion. Aflac had a return on equity of 16.22% and a net margin of 28.35%. The business’s revenue was down .7% on a year-over-year basis. During the same quarter last year, the firm earned $1.58 EPS. As a group, research analysts expect that Aflac Incorporated will post 6.75 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, September 2nd. Shareholders of record on Wednesday, August 21st were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.85%. The ex-dividend date of this dividend was Wednesday, August 21st. Aflac’s dividend payout ratio is presently 22.08%.

Analyst Upgrades and Downgrades

A number of equities research analysts have weighed in on AFL shares. UBS Group lifted their target price on Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a report on Wednesday, August 14th. Piper Sandler lifted their price target on Aflac from $95.00 to $100.00 and gave the company an “overweight” rating in a research report on Friday, June 28th. Morgan Stanley raised their price target on Aflac from $91.00 to $98.00 and gave the company an “equal weight” rating in a report on Monday, August 19th. Truist Financial lifted their price objective on Aflac from $82.00 to $100.00 and gave the stock a “hold” rating in a report on Friday, August 2nd. Finally, Citigroup lifted their price objective on Aflac from $84.00 to $93.00 and gave the stock a “neutral” rating in a research report on Tuesday, July 23rd. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and three have given a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $92.50.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.